Otelixizumab Antibody
Otelixizumab (ChAglyCD3) is a chimeric anti-CD3 monoclonal antibody investigated for modulating T-cell activity. Its research applications focus on autoimmune disorders, particularly Type 1 diabetes, with studies conducted in both in vitro assays and clinical in vivo trials to assess immunomodulatory effects.
Product Specifications
Product Name Alternative
GSK2136525, GSK-2136525, ChAglyCD3, TRX4, TRX 4
Target
Integrin, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
11.61 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
144.58 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog